Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FAKJL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,987
Award facts
- Contract value 100% obligated
- $35,987.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,987.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Jardiance order represents a routine task order under the DLA's broader pharmaceutical prime vendor program, which utilizes firm fixed-price mechanisms to supply medications across multiple therapeutic domains to military treatment facilities and veterans' healthcare programs. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning qualified contractors like AmerisourceBergen to continue serving as essential suppliers of prescription medications and medical commodities to federal healthcare agencies.
Quick answers
Who was awarded contract SPE2DR26FAKJL?
SPE2DR26FAKJL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FAKJL worth?
The government has obligated $35,987 on SPE2DR26FAKJL.
Is contract SPE2DR26FAKJL an order under another contract?
Yes. SPE2DR26FAKJL is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKJL competed?
The extent of competition for SPE2DR26FAKJL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award